Zacks Research Forecasts Nukkleus’ Q2 Earnings (NASDAQ:DFNS)

Nukkleus Inc. (NASDAQ:DFNSFree Report) – Research analysts at Zacks Research issued their Q2 2026 EPS estimates for shares of Nukkleus in a report issued on Wednesday, June 24th. Zacks Research analyst T. Kerr forecasts that the company will earn ($0.05) per share for the quarter. Zacks Research also issued estimates for Nukkleus’ Q3 2026 earnings at ($0.04) EPS, Q4 2026 earnings at ($0.03) EPS, FY2026 earnings at ($0.99) EPS, FY2027 earnings at ($0.04) EPS, FY2028 earnings at $0.01 EPS, FY2029 earnings at $0.03 EPS and FY2030 earnings at $0.06 EPS.

A number of other analysts have also recently weighed in on the stock. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Nukkleus in a research report on Thursday, June 18th. Wall Street Zen lowered Nukkleus from a “hold” rating to a “sell” rating in a research report on Saturday, April 18th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Sell”.

Check Out Our Latest Report on Nukkleus

Nukkleus Stock Performance

Shares of DFNS stock opened at $0.18 on Friday. The company has a current ratio of 0.25, a quick ratio of 0.21 and a debt-to-equity ratio of 0.07. The company has a market cap of $10.73 million, a PE ratio of -0.06 and a beta of -6.00. The company’s fifty day simple moving average is $0.39 and its 200-day simple moving average is $1.81. Nukkleus has a 52 week low of $0.16 and a 52 week high of $15.59.

Nukkleus (NASDAQ:DFNSGet Free Report) last announced its quarterly earnings results on Wednesday, May 20th. The company reported ($1.14) earnings per share for the quarter. The business had revenue of $3.65 million for the quarter.

Institutional Trading of Nukkleus

Hedge funds have recently made changes to their positions in the company. GM Advisory Group LLC acquired a new position in shares of Nukkleus during the fourth quarter worth $56,000. BNP Paribas Financial Markets purchased a new stake in Nukkleus during the 2nd quarter worth $56,000. Price T Rowe Associates Inc. MD purchased a new stake in Nukkleus during the 4th quarter worth $57,000. Millennium Management LLC acquired a new position in Nukkleus in the 4th quarter worth $60,000. Finally, State Street Corp lifted its holdings in Nukkleus by 70.7% in the 4th quarter. State Street Corp now owns 17,863 shares of the company’s stock worth $72,000 after buying an additional 7,400 shares in the last quarter. Hedge funds and other institutional investors own 12.47% of the company’s stock.

Key Nukkleus News

Here are the key news stories impacting Nukkleus this week:

  • Positive Sentiment: Nukkleus recently announced that its defense-focused business, T3 Defense, will present at the Maxim Group Defense Tech and Domestic Supply Chain Virtual Conference, which can help raise investor visibility and interest in the stock. Article Title
  • Neutral Sentiment: Zacks Research issued a set of earnings estimates for Nukkleus across fiscal 2026 through 2030, including a projected FY2026 loss of $0.99 per share followed by a gradual path toward small profits later in the forecast period. The estimates give investors a new benchmark, but they do not appear to be a major positive or negative surprise on their own.
  • Negative Sentiment: Short interest jumped sharply in June to 12.7 million shares, with about 27.1% of the float sold short. That signals significant bearish sentiment and highlights elevated skepticism around the stock’s outlook. Article Title

About Nukkleus

(Get Free Report)

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.

See Also

Receive News & Ratings for Nukkleus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nukkleus and related companies with MarketBeat.com's FREE daily email newsletter.